163 related articles for article (PubMed ID: 17672931)
1. [Preparation of functional antibodies targeting tumor endothelia for the treatment of hepatic carcinoma].
Hu H; Ran YL; Yu L; Zhou Z; Lou JN; Yang ZH
Ai Zheng; 2007 May; 26(5):453-7. PubMed ID: 17672931
[TBL] [Abstract][Full Text] [Related]
2. [Establishment and application of engrafted tumor models with humanized tumor blood vessel].
Ran YL; Zhong X; Hu H; Yu L; Lou JN; Yang ZH
Ai Zheng; 2006 Nov; 25(11):1323-8. PubMed ID: 17094895
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody to human esophageal cancer endothelium inhibits angiogenesis and tumor growth.
Zhang Y; Ran Y; Yu L; Hu H; Zhou Z; Sun L; Lou J; Yang Z
Anticancer Res; 2006; 26(4B):2963-70. PubMed ID: 16886621
[TBL] [Abstract][Full Text] [Related]
4. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
5. Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.
Goto T; Ishikawa H; Matsumoto K; Nishimura D; Kusaba M; Taura N; Shibata H; Miyaaki H; Ichikawa T; Hamasaki K; Nakao K; Maeshima Y; Eguchi K
Int J Oncol; 2008 Jul; 33(1):33-40. PubMed ID: 18575748
[TBL] [Abstract][Full Text] [Related]
6. Anti-endostatin monoclonal antibody enhances growth of human hepatocellular carcinoma cells by inhibiting activity of endostatin secreted by the transplanted cells in nude mice.
Tsuboi S; Nouso K; Tomono Y; Nagamori S; Naito I; Watanabe T; Manabe K; Ohmori H; Nakatsukasa H; Miyazaki M; Higashi T; Shiratori Y; Namba M; Ninomiya Y
Int J Oncol; 2004 Nov; 25(5):1267-71. PubMed ID: 15492814
[TBL] [Abstract][Full Text] [Related]
7. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334
[TBL] [Abstract][Full Text] [Related]
8. Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells.
Hanyu A; Kojima K; Hatake K; Nomura K; Murayama H; Ishikawa Y; Miyata S; Ushijima M; Matsuura M; Ogata E; Miyazawa K; Imamura T
Cancer Sci; 2009 Nov; 100(11):2085-92. PubMed ID: 19719773
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of the therapeutic effects of an anti-endothelial cell monoclonal antibody BVE-1 for solid tumor xenograft in nude mice].
Li P; Yuan M; Xia H
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):280-3. PubMed ID: 10920984
[TBL] [Abstract][Full Text] [Related]
10. [Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice].
Song CC; Lu X; Cheng BB; DU J; Li B; Ling CQ
Ai Zheng; 2007 Dec; 26(12):1315-22. PubMed ID: 18076793
[TBL] [Abstract][Full Text] [Related]
11. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
Raskopf E; Vogt A; Sauerbruch T; Schmitz V
J Hepatol; 2008 Dec; 49(6):977-84. PubMed ID: 18845354
[TBL] [Abstract][Full Text] [Related]
12. RhoC is essential for angiogenesis induced by hepatocellular carcinoma cells via regulation of endothelial cell organization.
Wang W; Wu F; Fang F; Tao Y; Yang L
Cancer Sci; 2008 Oct; 99(10):2012-8. PubMed ID: 19016761
[TBL] [Abstract][Full Text] [Related]
13. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; MartÃnez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.
Torimura T; Ueno T; Kin M; Taniguchi E; Nakamura T; Inoue K; Sakata R; Hashimoto O; Sakamoto M; Ohira H; Kumashiro R; Sata M; Yano H; Kojiro M; Veitonmaki N; Cao Y
Gastroenterology; 2006 Apr; 130(4):1301-10. PubMed ID: 16618420
[TBL] [Abstract][Full Text] [Related]
15. [Targeting therapy with adriamycin-monoclonal antibody (HAb18) conjugate in nude mice with human hepatocellular carcinoma xenografts].
Sui Y
Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):397-400, 445. PubMed ID: 1330227
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus-mediated expression of apolipoprotein (a) kringles suppresses hepatocellular carcinoma growth in mice.
Lee K; Yun ST; Kim YG; Yoon Y; Jo EC
Hepatology; 2006 May; 43(5):1063-73. PubMed ID: 16628632
[TBL] [Abstract][Full Text] [Related]
17. [Application of radiolabeled anti-HBx monoclonal antibody for HCC targeting therapy].
Li J; Tang Z; Liu K
Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):271-4. PubMed ID: 8758272
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells transduced with TEM8 recombinant adenovirus prevents hepatocellular carcinoma angiogenesis and inhibits cells growth.
Yang X; Zhu H; Hu Z
Vaccine; 2010 Oct; 28(43):7130-5. PubMed ID: 20650339
[TBL] [Abstract][Full Text] [Related]
19. Effects of the augmenter of liver regeneration on the biological behavior of hepatocellular carcinoma.
Tang L; Sun H; Zhang L; Deng JC; Guo H; Zhang L; Liu Q
Saudi Med J; 2009 Aug; 30(8):1001-9. PubMed ID: 19668879
[TBL] [Abstract][Full Text] [Related]
20. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
